Home
Photo of Per Hammarström

Per Hammarström

Professor

Publications

2024

Lovisa Johansson, Alexander Sandberg, Sofie Nyström, Per Hammarström, Martin Hallbeck (2024) Amyloid beta 1-40 and 1-42 fibril ratios and maturation level cause conformational differences with minimal impact on autophagy and cytotoxicity Journal of Neurochemistry (Article in journal) Continue to DOI
Farjana Parvin, Samuel Haglund, Bettina Wegenast-Braun, Mathias Jucker, Takashi Saito, Takaomi C. Saido, Peter Nilsson, Per Nilsson, Sofie Nyström, Per Hammarström (2024) Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and AppNL-F Mice ACS Chemical Neuroscience, Vol. 15, p. 2058-2069 (Article in journal) Continue to DOI
Per Hammarström (2024) The Transthyretin Protein and Amyloidosis - an Extraordinary Chemical Biology Platform Israel Journal of Chemistry (Article, review/survey) Continue to DOI
Linnea Björk, Robert Selegård, Marcus Bäck, Per Hammarström, Mikael Lindgren, Peter Nilsson (2024) Amino-Acid Side-Chain Nanoarchitectonics for Tuning the Chiroptical Properties and Supramolecular Structure of Pentameric Oligothiophenes ChemPhotoChem (Article in journal) Continue to DOI

2023

Per Hammarström, Sofie Nyström (2023) Viruses and amyloids-a vicious liaison Prion, Vol. 17, p. 82-104 (Article, review/survey) Continue to DOI

News

Electron microscopy image showing amyloid of corona virus spike protein.

Possible discovery of mechanism behind mysterious COVID-19 symptoms

The immune system can affect the SARS-CoV-2 spike protein, leading to the production of a misfolded spike protein called amyloid. A new study points to a possible connection between harmful amyloid production and symptoms of COVID-19.
Pipette in chemistrylab.

Master’s programme in protein science now open for international students

Linköping University will open its Protein Science master’s programme to international students starting next year. The programme combines theoretical and practical components, with a heavy emphasis on laboratory work.
Martin Hallbeck and Per Hammarström

Two pieces of the Alzheimer’s puzzle

One is a protein chemist, the other a physician. Both conduct research into Alzheimer’s disease. Each benefits from the knowledge of the other, making progress more rapid. Their objective: to make a difference for those affected by disease.

Tags